Skip to Content
Merck
CN
  • Synaptic signaling by all-trans retinoic acid in homeostatic synaptic plasticity.

Synaptic signaling by all-trans retinoic acid in homeostatic synaptic plasticity.

Neuron (2008-10-30)
Jason Aoto, Christine I Nam, Michael M Poon, Pamela Ting, Lu Chen
ABSTRACT

Normal brain function requires that the overall synaptic activity in neural circuits be kept constant. Long-term alterations of neural activity lead to homeostatic regulation of synaptic strength by a process known as synaptic scaling. The molecular mechanisms underlying synaptic scaling are largely unknown. Here, we report that all-trans retinoic acid (RA), a well-known developmental morphogen, unexpectedly mediates synaptic scaling in response to activity blockade. We show that activity blockade increases RA synthesis in neurons and that acute RA treatment enhances synaptic transmission. The RA-induced increase in synaptic strength is occluded by activity blockade-induced synaptic scaling. Suppression of RA synthesis prevents synaptic scaling. This form of RA signaling operates via a translation-dependent but transcription-independent mechanism, causes an upregulation of postsynaptic glutamate receptor levels, and requires RARalpha receptors. Together, our data suggest that RA functions in homeostatic plasticity as a signaling molecule that increases synaptic strength by a protein synthesis-dependent mechanism.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Insulin human, meets USP testing specifications
Sigma-Aldrich
Insulin human, ≥95% (HPLC), semisynthetic, powder, non-sterile
Sigma-Aldrich
Actinomycin D, from Streptomyces sp., ≥95% (HPLC)
Sigma-Aldrich
Retinoic acid, ≥98% (HPLC), powder
Sigma-Aldrich
Insulin human, recombinant, expressed in yeast (proprietary host)
Sigma-Aldrich
Insulin human, recombinant, expressed in yeast, γ-irradiated, suitable for cell culture
Sigma-Aldrich
Citral, 95%
Sigma-Aldrich
Citral, mixture of cis and trans, ≥96%, FG